ANI Pharmaceuticals Inc ANIP:NASDAQ

Last Price$37.61NASDAQ Previous Close - Last Trade as of 4:00PM ET 3/24/23
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$37.46 (2)
Ask (Size)$39.16 (1)
Day Low / HighN/A - N/A
Volume60.3 K

View Biotechnology IndustryPeer Comparison as of 03/24/2023


ANI Pharmaceuticals Inc ( NASDAQ )

Price: $37.61
Change: -0.21 (0.56%)
Volume: 60.3 K
4:00PM ET 3/24/2023

Anavex Life Sciences Corp ( NASDAQ )

Price: $8.72
Change: +0.04 (0.46%)
Volume: 1.1 M
4:00PM ET 3/24/2023

Cogent Biosciences Inc ( NASDAQ )

Price: $10.11
Change: +0.07 (0.70%)
Volume: 538.4 K
4:00PM ET 3/24/2023

Immunitybio Inc ( NASDAQ )

Price: $1.64
Change: +0.18 (12.33%)
Volume: 4.0 M
4:00PM ET 3/24/2023

Seres Therapeutics Inc ( NASDAQ )

Price: $5.69
Change: +0.02 (0.35%)
Volume: 864.0 K
4:00PM ET 3/24/2023

Read more news Recent News

HC Wainwright Adjusts Price Target on ANI Pharmaceuticals to $53 From $50, Keeps Buy Rating
7:34AM ET 3/13/2023 MT Newswires

ANI Pharmaceuticals (ANIP) has an average rating of outperform and price targets ranging from $40 to $55, according to analysts polled by Capital IQ. (MT...

ANI Pharmaceuticals Q4 Adjusted Earnings, Revenue Rise; 2023 Guidance Issued
7:13AM ET 3/09/2023 MT Newswires

ANI Pharmaceuticals (ANIP) reported Q4 adjusted earnings early Thursday of $0.76 per diluted share, up from $0.06 a year earlier. Analysts polled by...

-- Earnings Flash (ANIP) ANI PHARMACEUTICALS Posts Q4 Revenue $94.2M, vs. Street Est of $86.1M
6:51AM ET 3/09/2023 MT Newswires


-- Earnings Flash (ANIP) ANI PHARMACEUTICALS Reports Q4 EPS $0.76, vs. Street Est of $0.67
6:50AM ET 3/09/2023 MT Newswires


Company Profile

Business DescriptionANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN. View company web site for more details
Address210 Main Street West
Baudette, Minnesota 56623
Number of Employees299
Recent SEC Filing03/10/20238-K
President, Chief Executive Officer & DirectorNikhil Lalwani
Senior VP-Operations & Product DevelopmentJames G. Marken
Chief Financial Officer & Senior VP-FinanceStephen P. Carey
Director & Head-Research & DevelopmentMuthusamy Shanmugam

Company Highlights

Price Open$37.49
Previous Close$37.82
52 Week Range$22.31 - 45.99
Market Capitalization$657.9 M
Shares Outstanding17.5 M
SectorHealth Technology
Next Earnings Announcement05/09/2023

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.54
Beta vs. S&P 500N/A
Revenue$201.6 M
Net Profit Margin-15.14%
Return on Equity-14.11%

Analyst Ratings as of 02/27/2023

Consensus RecommendationConsensus Icon
Powered by Factset